Antiepileptic Drug Treatment Patterns in Women of Childbearing Age with Epilepsy
JAMA Neurol 76:783-790, Kim, H.,et al, 2019
Risk of 23 Specific Malformations Associated with Prenatal Exposure to 10 Antiepileptic Drugs
Neurol 93:e167-e180, Blotiere, P.O.,et al, 2019
Vestibular Migraine
BMJ 366:L4213, Li, V.,et al, 2019
Trial of Amitriptyline, Topiramate, and Placebo for Pediatric Migraine
NEJM 376:115-124, Powers, S.W.,et al, 2016
Chronic Migraine
BMJ 348:g141b, Schwedt, T.J., 2014
Randomized Trial of Adjunctive Topiramate Therapy in Infants with Refractory Partial Seizures
Neurol 74:714-720, Novotny,E.,et al, 2010
Topiramate in Pregnancy: Preliminary Experience From the UK Epilepsy and Pregnancy Register
Neurol 71:272-276, Unt,S.,et al., 2008
The SANAD Study of Effectiveness of Valproate,Lamotrigine,or Topiramate for Generalised and Unclassifiable Epilepsy:An Unblinded Randomised Controlled Trial
Lancet 369:1016-1026, Marson,A.G.,et al, 2007
Epilepsy Syndromes in Infancy
Pediatr Neurol 34:253-263, Korff,C.M. &Nordii,D.R.,Jr., 2006
Efficacy and Tolerability of the New Antiepleptic Drugs II: Treatment of Refractory Epilepsy
Neurol 62:1261-1273, French,J.A.,et al, 2004
The Use of Topiramate in Refractory Status Epilepticus
Neurol 60:332-334, Towne,A.R.,et al, 2003
Randomized, Concentration-Controlled Trial of Topiramate in Refractory Focal Epilepsy
Neurol 61:1210-1218, Christensen,J.,et al, 2003
Acute Myopia and Angle-Closure Glaucoma Induced by Topiramate
Neurol 61:1306, Boentert,M.,et al, 2003
SUNCT Syndrome: Prolonged Attacks, Refractoriness and Response to Topiramate
Neurol 58:1307, Matharu,M.S.,et al, 2002
Uveal Effusion and Secondary Angle-Closure Glaucoma Associated with Topiramate Use
Arch Ophthalmol 119:1210-1211, Sankar,P.S., 2001
Valproate-Induced Hyperammonemic Encephalopathy in the Presence of Topiramate
Neurol 54:230-232, Hamer,H.M.,et al, 2000
New Antiepileptic Drugs:A Systematic Review of Their Efficacy and Tolerability
BMJ 313:1169-1174, 1157, 1158996., Marson,A.G.,et al, 1996
Topiramate Placebo-Controlled Dose-Ranging Trial in Refractory partial Epilepsy Using 200-, 400-, and 600-mg Daily Dosages
Neurol 46:1684-1690, Faught,E.,et al, 1996